This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...